BIOREGENX, INC. Asset Acquisition Consideration Transferred Transaction Cost
BIOREGENX, INC. (BRGX) reported Asset Acquisition Consideration Transferred Transaction Cost of $12.29 thousand for the 3-month period ending 2024-03-31, per its 10-Q/A filed 2024-10-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost · last filed 2024-10-09
- BIOREGENX, INC. asset acquisition consideration transferred transaction cost for the quarter ending 2024-03-31 was $12.29K.
| Period end | Asset Acquisition Consideration Transferred Transaction Cost 3 month |
|---|---|
| 2024-03-31 | $12.29K 10-Q/A · filed 2024-10-09 |